tirzepatide eyesight Eye Complications Found With Use of Semaglutide, Comparative ocular outcomes of tirzepatide

It is not FDA-approved for weight loss, diabetes, or any other indication

[PMID: 23755725] PubMed record related to this compound for laboratory literature review

Unfortunately, technology and processed foods have made it difficult for us to maintain a healthy body composition

Telehealth obesity platforms including Hims and Hers , Ro , and Noom Med collectively supported more than 3.1 million active GLP-1 prescriptions as of Q1 2026 , delivering AI-powered dosage guidance, nutrition coaching, behavioral health support, and automated refill management within subscription platforms

The extra-pancreatic effects of GLP-1 receptor agonists: A focus on the cardiovascular, gastrointestinal and central nervous systems

But with few clinical trials to back their efficacyand safetyor, in this case, the absence of regulatory approval, its a veritable wild west